SUSTANON"250"

Main information

  • Trade name:
  • SUSTANON"250" solution for injection
  • Pharmaceutical form:
  • solution for injection
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • SUSTANON"250" solution for injection
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Testosterone
  • Product summary:
  • Suitability for use in older adult patients Testosteroni propionas Avoid using for elderly persons. May be considered in cases of moderate or severe hypogonadism. Do not use on patients with prostate cancer. Significant adverse effects include elevated blood pressure and psychiatric disorders. Take interactions into account. Testosteroni isocaproas Avoid using for elderly persons. May be considered in cases of moderate or severe hypogonadism. Do not use on patients with prostate cancer. Significant adverse effects include elevated blood pressure and psychiatric disorders. Take interactions into account. Testosteroni phenylpropionas Avoid using for elderly persons. May be considered in cases of moderate or severe hypogonadism. Do not use on patients with prostate cancer. Significant adverse effects include elevated blood pressure and psychiatric disorders. Take interactions into account. Testosteroni decanoas Avoid using for elderly persons. May be considered in cases of moderate or severe hypogonadism. Do not use on patients with prostate cancer. Significant adverse effects include elevated blood pressure and psychiatric disorders. Take interactions into account.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 3811
  • Authorization date:
  • 07-03-2008
  • Last update:
  • 26-07-2018